Back
Also listed as
SAFLF
OTC
Day Range
$4.00
$4.00
52-Week Range
$2.23
$4.00
Volume
300
50D / 200D Avg
$4.00
/
$3.42
Prev Close
$4.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 25.5 | 0.4 |
| P/B | 3.1 | 2.9 |
| ROE % | 11.7 | 3.8 |
| Net Margin % | 5.0 | 3.9 |
| Rev Growth 5Y % | -0.7 | 10.0 |
| D/E | 0.3 | 0.2 |
Key Takeaways
Revenue declined -0.65% annually over 5 years
Earnings grew 111.41% over the past year
ROE of 11.71% — decent returns on equity
Debt/Equity of 0.25 — conservative balance sheet
Generating 78.07M in free cash flow
PEG of 0.02 suggests growth is underpriced
Growth
Revenue Growth (5Y)
-0.65%
Revenue (1Y)-4.90%
Earnings (1Y)111.41%
FCF Growth (3Y)50.43%
Quality
Return on Equity
11.71%
ROIC9.43%
Net Margin4.99%
Op. Margin6.53%
Safety
Debt / Equity
0.25
Current Ratio1.71
Interest Coverage7.76
Valuation
P/E Ratio
25.54
P/B Ratio3.07
EV/EBITDA20.27
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.90% | Revenue Growth (3Y) | -3.99% |
| Earnings Growth (1Y) | 111.41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0.65% | Earnings Growth (5Y) | 22.00% |
| Profitability | |||
| Revenue (TTM) | 944.57M | Net Income (TTM) | 47.14M |
| ROE | 11.71% | ROA | 6.21% |
| Gross Margin | 60.94% | Operating Margin | 6.53% |
| Net Margin | 4.99% | Free Cash Flow (TTM) | 78.07M |
| ROIC | 9.43% | FCF Growth (3Y) | 50.43% |
| Safety | |||
| Debt / Equity | 0.25 | Current Ratio | 1.71 |
| Interest Coverage | 7.76 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 25.54 | P/B Ratio | 3.07 |
| P/S Ratio | 1.27 | PEG Ratio | 0.02 |
| EV/EBITDA | 20.27 | Dividend Yield | 0.00% |
| Market Cap | 1.20B | Enterprise Value | 1.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 944.57M | 993.22M | 1.02B | 1.08B | 969.58M |
| Net Income | 47.14M | 22.30M | -24.65M | 54.16M | 21.28M |
| EPS (Diluted) | 0.22 | 0.05 | -0.06 | 0.13 | 0.07 |
| Gross Profit | 575.63M | 592.78M | 601.74M | 597.45M | 445.64M |
| Operating Income | 61.65M | 39.39M | 7.66M | 48.46M | 26.08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 758.63M | 842.34M | 855.46M | 960.27M | 937.77M |
| Total Liabilities | 355.75M | 414.88M | 459.68M | 521.35M | 571.68M |
| Shareholders' Equity | 392.29M | 413.07M | 379.20M | 409.92M | 326.74M |
| Total Debt | 98.23M | 130.10M | 157.60M | 191.11M | 192.96M |
| Cash & Equivalents | 52.12M | 47.42M | 74.90M | 77.71M | 99.00M |
| Current Assets | 448.13M | 510.56M | 547.67M | 596.30M | 561.89M |
| Current Liabilities | 262.33M | 277.45M | 289.08M | 312.55M | 310.63M |